(S (NP (ADJP (FW In) (FW silico)) (NN drug) (HYPH -) (NN target) (NN interaction) (PRN (-LRB- -LRB-) (NP (NN DTI)) (-RRB- -RRB-)) (NN prediction)) (VP (VBZ is) (NP (NP (DT an) (ADJP (JJ important) (CC and) (JJ challenging)) (NN problem)) (PP (IN in) (NP (NP (JJ biomedical) (NN research)) (PP (IN with) (NP (NP (DT a) (JJ huge) (JJ potential) (NN benefit)) (PP (IN to) (NP (NP (DT the) (NN pharmaceutical) (NN industry)) (CC and) (NP (NNS patients)))))))))) (. .))
(S (S (NP (NP (JJS Most)) (VP (VBG existing) (NP (NNS methods)) (PP (IN for) (NP (NP (NN DTI) (NN prediction)) (PP (VBG including) (NP (NML (JJ deep) (NN learning)) (NNS models))))))) (ADVP (RB generally)) (VP (VBP have) (NP (NP (JJ binary) (NNS endpoints)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD could) (VP (VB be) (NP (NP (DT an) (NN oversimplification)) (PP (IN of) (NP (DT the) (NN problem))))))))))) (, ,) (CC and) (S (NP (DT those) (NNS methods)) (VP (VBP are) (ADVP (RB typically)) (ADJP (JJ unable) (S (VP (TO to) (VP (VB handle) (NP (NP (NML (JJ cold) (HYPH -) (NN target)) (NNS problems)) (, ,) (NP (ADVP (FW i.e.)) (, ,) (NP (NNS problems)) (VP (VBG involving) (NP (NP (NN target) (NN protein)) (SBAR (WHNP (WDT that)) (S (ADVP (RB never)) (VP (VBD appeared) (PP (IN in) (NP (DT the) (NN training) (NN set)))))))))))))))) (. .))
(NP (NP (PP (IN Towards) (NP (DT this))) (, ,) (NP (PRP we)) (PRN (NP (JJ contrived) (NN PADME)) (-LRB- -LRB-) (NP (NML (NN Protein) (CC And) (NN Drug)) (NML (NN Molecule) (NN interaction)) (NN prEdiction)) (-RRB- -RRB-)) (, ,) (NP (DT a) (NN framework))) (VP (VBN based) (PP (IN on) (NP (JJ Deep) (JJ Neural) (NNS Networks))) (, ,) (S (VP (TO to) (VP (VB predict) (NP (NP (ADJP (JJ real) (HYPH -) (VBN valued)) (NN interaction) (NN strength)) (PP (IN between) (NP (NNS compounds) (CC and) (NN proteins)))) (PP (IN without) (S (VP (VBG requiring) (NP (NN feature) (NN engineering))))))))) (. .))
(S (NP (NNP PADME)) (VP (VBZ takes) (NP (NML (CC both) (NN compound) (CC and) (NN protein)) (NN information)) (PP (IN as) (NP (NNS inputs))) (, ,) (SBAR (IN so) (S (NP (PRP it)) (VP (VBZ is) (ADJP (JJ capable) (PP (IN of) (S (VP (VBG solving) (NP (NML (NML (JJ cold) (HYPH -) (NN target)) (-LRB- -LRB-) (CC and) (NML (JJ cold) (HYPH -) (NN drug)) (-RRB- -RRB-)) (NNS problems)))))))))) (. .))
(S (PP (IN To) (NP (PRP$ our) (NN knowledge))) (, ,) (NP (PRP we)) (VP (VBP are) (NP (DT the) (JJ first) (S (VP (TO to) (VP (VB combine) (NP (NP (NP (NNP Molecular) (NNP Graph) (NNP Convolution)) (-LRB- -LRB-) (NP (NNP MGC)) (-RRB- -RRB-)) (PP (IN for) (NP (NN compound) (NN featurization)))) (PP (IN with) (NP (NP (NN protein) (NNS descriptors)) (PP (IN for) (NP (NN DTI) (NN prediction)))))))))) (. .))
(S (S (NP (PRP We)) (VP (VBD used) (NP (NP (JJ multiple) (NN cross-validation) (NN split) (NNS schemes)) (CC and) (NP (NN evaluation) (NNS metrics))) (S (VP (TO to) (VP (VB measure) (NP (NP (DT the) (NN performance)) (PP (IN of) (NP (NNP PADME)))) (PP (IN on) (NP (JJ multiple) (NNS datasets))) (, ,) (PP (VBG including) (NP (DT the) (NNP ToxCast) (NN dataset)))))))) (, ,) (CC and) (S (NP (NNP PADME)) (ADVP (RB consistently)) (VP (VBZ dominates) (NP (NN baseline) (NNS methods)))) (. .))
(S (NP (NP (NP (DT The) (NNS results)) (PP (IN of) (NP (DT a) (NN case) (NN study)))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ predicts) (NP (NP (DT the) (NN binding) (NN affinity)) (PP (IN between) (NP (NP (JJ various) (NNS compounds)) (CC and) (NP (NN androgen)) (NML (NN receptor) (-LRB- -LRB-) (NN AR) (-RRB- -RRB-)))))))) (, ,)) (VP (VBP suggest) (NP (NP (NP (NNP PADME) (POS 's)) (NN potential)) (PP (IN in) (NP (NN drug) (NN development))))) (. .))
(S (NP (NP (DT The) (NN scalability)) (PP (IN of) (NP (NNP PADME)))) (VP (VBZ is) (NP (NP (DT another) (NN advantage)) (PP (IN in) (NP (NP (DT the) (NN age)) (PP (IN of) (NP (NNP Big) (NNP Data))))))) (. .))
